drugset / Trial / NCT05105815
Safety and Efficacy of Autoimmune Cell Therapy for Patients With Hepatocellular Carcinoma
Phase 0
Unknown
23 enrolled
Huashan Hospital
Beijing Immupeutics Medicine Technology Limited · collabPeking University People's Hospital · collab
NaSingle-groupOpen-labelTreatment
Summary
In this study, safety and effects of IPM001 vaccine on human hepatocellular carcinoma are going to be investigated, IPM001 is a neoantigen/tumor-specific antigen sensitized autoimmune cell injection
Timeline
- Start
- 2021-12-31
- Primary completion
- 2023-12-31
- Completion
- 2024-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IPM001 | Cell therapy | — | — |